Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 66

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 66
---
 establishment and periodic review of the Company’s measures for receiving feedback from security holders; |

| 21. | the development of clear position descriptions for directors, including the Chair of the Board, a “Lead Independent Director” and the chair of each board committee; and, together with the CEO, a clear position description for the CEO, which includes delineating management’s responsibilities; |

| 22. | the oversight of the management of environmental risks and practices, charitable activities and other social responsibility matters; and |

| 23. | to the extent not otherwise referred to above, the review and approval of all proposed transactions and matters described below under the heading “B. Decisions Requiring Prior Approval of the Board” |

and, where applicable, in accordance with the requirements of the Canada Business Corporations Act, the stock exchanges on which the Company lists its securities and securities regulatory authorities, as adopted or in force or amended from time to time. In discharging its duties and responsibilities, the Board of Directors is expected to be fully diligent in its oversight to avoid fraud or abuse. Accordingly, the Board may conduct such examinations, investigations or inquiries, and engage such special legal, accounting or other advisors, at the expense of the Company, at such time or times and on such terms and conditions as the Board of Directors considers appropriate. B.Decisions Requiring Prior Approval of the Board In addition to such other approvals as required by applicable law or the stock exchanges on which the Company lists its securities and securities regulatory authorities, the Board (or the committees of the Board duly constituted by the Board to the extent such delegation is permitted by law and is specifically made by the Board of Directors) shall review and approve:

| 1. | the strategic plan, financial plans and operating budget of the Company on at least an annual basis; |

| 2. | the quarterly and annual financial statements of the Company; |

Page43

| 3. | all material capital expenditures not part of the approved operating budget, all mergers and acquisitions, and all material investments and dispositions of the Company; |

| 4. | all material borrowings and banking arrangements of the Company; |

| 5. | all financing by the Company including the issuance of debt, equity and derivative instruments; for greater certainty, this includes the approval of all off-balance sheet financings by the Company or by special purpose entities or affiliates; |

| 6. | the purchase and redemption of securities; |

| 7. | any changes to the articles or by